Tue.Dec 26, 2023

article thumbnail

AstraZeneca Goes With Gracell to Gain an Edge in Next-Generation Cell Therapies

MedCity News

AstraZeneca is paying $1 billion up front to acquire Gracell Biotechnologies, a clinical-stage cell therapy developer. The deal is the latest in a series of AstraZeneca moves intended to expand its presence in the burgeoning cell therapy field.

Biopharma 312
article thumbnail

How To Break Into Trauma Med Sales With Joseph Hutchison

Evolve Your Success

There is a myth that medical sales are very hard to get into, but if you put the time and effort into this program, you will get the job that you want. This is what Joseph “Joey” Hutchison learned from his successful journey in medical sales. After going through the Medical Sales Career Builder program, he was able to break into trauma med sales in just three months.

Sales 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bristol Myers Squibb Makes Another M&A Move, Striking $4B Deal for RayzeBio

MedCity News

By acquiring RayzeBio, Bristol Myers Squibb gains a pipeline of radiopharmaceuticals and the infrastructure for manufacturing these targeted cancer therapies. In the second half of 2023 alone, BMS has committed about $24 billion to business development deals.

article thumbnail

AZ makes another cell therapy play with $1.2bn Gracell buy

pharmaphorum

AstraZeneca agrees a $1.

110
110
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

Predictions for Healthcare Price Transparency in 2024

MedCity News

In looking ahead to 2024, the healthcare industry stands at the cusp of a transformative era of transparency. With impending regulatory changes and growing consumer empowerment, the landscape is poised for continued meaningful progress.

More Trending

article thumbnail

Report: The Top 4 Contributors To Food Insecurity

MedCity News

The contributors to food insecurity include age, having a disability, being on a fixed income and being a single parent, according to a recent report from FarmboxRx.

Food 278
article thumbnail

BMS agrees to acquire Karuna Therapeutics for $14bn

Pharmaceutical Technology

Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition of Karuna Therapeutics for $14bn in cash.

97
article thumbnail

New Healthcare Climate Initiatives Lack Teeth, But They’re Paving the Way

MedCity News

Hospitals and hospital systems need to make clearer and more consistent demands for climate accountability from their suppliers, and they need to follow through with preferred green vendor programs and the like.

article thumbnail

Top 5 AI Stories of 2023

PharmExec

As this exciting technology exploded in 2023, Pharm Exec was there to cover it all.

64
article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

article thumbnail

KSQ-4279 by F. Hoffmann-La Roche for Ovarian Cancer: Likelihood of Approval

Pharmaceutical Technology

KSQ-4279 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Ovarian Cancer.

53
article thumbnail

Top Social Media Trends of 2023

PharmExec

Five trends in pharmaceutical marketing from the past year.

Media 59
article thumbnail

8 Tips to Build an Effective Manufacturing Sales Strategy

Spotio

Manufacturing sales is anything but simple. Fortunately, it’s far from impossible. You just need to implement an effective manufacturing sales strategy to meet your company’s revenue goals. We can help you with that! Once you equip your sales team with the strategy and technology they need to close deals, they’ll do so at a consistent clip.

article thumbnail

Difficult biotech investment ecosystem forces focus on value

Pharmaceutical Technology

In 2023, investors pursued pharmaceutical assets with value amidst an unstable economic environment.

article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Navigating the Complexities of Medical Sales Staff Recruitment: A Comprehensive Guide

Rep-Lite

Recruiting medical staff, including non-clinical roles such as device equipment specialists, department managers, or medical sales representatives, involves several complexities due to the unique nature of the healthcare industry. Medical sales staff recruitment firms may face challenges such as finding the right talent, ensuring compliance, incorporating innovation, and others.

article thumbnail

AWT-020 by Anwita Biosciences for Sarcomas: Likelihood of Approval

Pharmaceutical Technology

AWT-020 is under clinical development by Anwita Biosciences and currently in Phase II for Sarcomas.

52
article thumbnail

A Record Year for Disease Elimination

PharmaTech

WHO provides a look at the world’s health as the agency turns 75.

52
article thumbnail

ABBV-400 by AbbVie for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

Pharmaceutical Technology

ABBV-400 is under clinical development by AbbVie and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

52
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Top 5 Most Popular Cold Chain Articles of 2023

Pharmaceutical Commerce

Items in this sector ranged touched on topics such as pharma shipping, container technology, and sustainability.

Pharma 52
article thumbnail

Exarafenib by Kinnate Biopharma for Non-Small Cell Lung Cancer: Likelihood of Approval

Pharmaceutical Technology

Exarafenib is under clinical development by Kinnate Biopharma and currently in Phase I for Non-Small Cell Lung Cancer.

article thumbnail

Top 5 Pharmacy Times Cardiovascular Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read cardiovascular-related articles on Pharmacy Times in 2023.

26
article thumbnail

AZD-9550 by AstraZeneca for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval

Pharmaceutical Technology

AZD-9550 is under clinical development by AstraZeneca and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH).

40
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Top 5 Pharmacy Times Clostridioides difficile Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read Clostridioides difficile-related articles on Pharmacy Times in 2023.

26
article thumbnail

ADRX-0706 by Adcentrx Therapeutics for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

Pharmaceutical Technology

ADRX-0706 is under clinical development by Adcentrx Therapeutics and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

40
article thumbnail

Top 5 Pharmacy Times Heart Failure Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read heart failure-related articles on Pharmacy Times in 2023.

26
article thumbnail

GS-4528 by Gilead Sciences for Metastatic Renal Cell Carcinoma: Likelihood of Approval

Pharmaceutical Technology

GS-4528 is under clinical development by Gilead Sciences and currently in Phase I for Metastatic Renal Cell Carcinoma.

40
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Inside Planned Parenthood’s Partnership-Centric Approach to Expanding Abortion Access

MedCity News

Ambreen Molitor, Planned Parenthood’s national director of venture and innovation, discussed three partnerships her organization has launched this year to address barriers to abortion care. These partnerships tackle barriers such as cost, changing state laws and lack of emotional support.

298
298
article thumbnail

BGB-30813 by BeiGene for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

Pharmaceutical Technology

BGB-30813 is under clinical development by BeiGene and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

40
article thumbnail

ORB-011 by Orionis Biosciences for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

Pharmaceutical Technology

ORB-011 is under clinical development by Orionis Biosciences and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

40